erlotinib hydrochloride has been researched along with Cardiac Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC; Chang, HJ; Chi, KH; Hsieh, YS; Hsu, PS; Jiang, JS; Kao, SJ; Tsang, YW; Yeh, YW | 1 |
| Arola, M; Kähkönen, M; Lohi, O; Parto, K; Vettenranta, K; Vornanen, M | 1 |
1 trial(s) available for erlotinib hydrochloride and Cardiac Cancer
| Article | Year |
|---|---|
Upfront gefitinib/erlotinib treatment followed by concomitant radiotherapy for advanced lung cancer: a mono-institutional experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Erlotinib Hydrochloride; Female; Gefitinib; Heart Neoplasms; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome | 2011 |
1 other study(ies) available for erlotinib hydrochloride and Cardiac Cancer
| Article | Year |
|---|---|
Recurrent congenital fibrosarcoma with heart metastases.
Topics: Erlotinib Hydrochloride; Female; Fibrosarcoma; Heart Neoplasms; Humans; Infant; Oncogene Proteins, Fusion; Pregnancy; Protein Kinase Inhibitors; Quinazolines; Recurrence | 2012 |